Our group
Our commitments
Our strategy
Our divisions
Pharmagest
Axigate Link
Medical Solutions
e-Connect
Fintech
Solutions
Finance
Agenda
Financial Analyses
Shareholders’ meetings
Documentation
Press releases
Financial contact
Voting Rights
Shareholders
Corporate Governance
Regulated information
L’Action Equasens
Durabilité
en
fr
Search
Search
Accueil
/
FY 2022 revenue: +10.88% to €214.07m
FY 2022 revenue: +10.88% to €214.07m
